Skip to content

Clinical trials

Observational Coronary Artery Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Observational Country / region: South Korea Clear all

150 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20053
20066
20072
20085
20094
20108
20118
20124
20135
20149
20157
201611
20176
20189
201913
20206
20218
202214
20238
20246
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Unknown status34
Recruiting30
Terminated9
Active, not recruiting8
Not yet recruiting3
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seung-Jung Park29
Yonsei University23
Seoul National University Hospital22
Samsung Medical Center9
Duk-Woo Park, MD5
Genoss Co., Ltd.5
Seoul National University Bundang Hospital5
Inje University4
Asan Medical Center3
Bon-Kwon Koo3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease150
Coronary Disease14
Cardiovascular Diseases13
Myocardial Ischemia13
Coronary Stenosis10
Myocardial Infarction8
Acute Coronary Syndrome6
Atherosclerosis6
Arterial Occlusive Diseases4
Diabetes Mellitus3

Trials

Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.

50 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.